Amplitude's sales fell nearly -14% for their fiscal year 2020 due to COVID-19, but the company's foot and ankle products still managed double-digit growth.
Second quarter revenue declines for DePuy Synthes were not as significant as expected. The company updated its 2020 guidance modeling reduced COVID impact.
Medicrea announced that it entered into an agreement to be acquired by Medtronic at a price of €7 (USD $8.01) per share with a 2020 estimated close date.
We expect 2Q20 orthopedic performance above consensus projections, but the U.S.’s inability to check the spread of COVID-19 will slow market recovery.
Increasing adoption of enabling technology, company consolidation through M&A, and accelerating growth of outpatient centers are COVID-proof orthopedic trends that will shape the market in 2021 and beyond.
The company’s orthopedic revenues for its fiscal fourth quarter fell -35% as it endured an additional month of COVID-related impact in April compared to competitors.